Huu S. TIEU Request for FDA to Establish Regenerating Human Cells as Law on December 13, 2016 President Barack H. Obama Singed the 21st Century CURES Act into FDA Regulation and Law

Abstract

Background and Aims: On November 24, 2009, Huu S. TIEU and Golden Sunrise Pharmaceutical, Inc. (Golden Sunrise) applied for the Technology and Innovation to be reviewed and evaluated by the U.S. Food and Drug Administration (FDA). In the review and evaluation, it was requested by Golden Sunrise designated the new indications for this application under Serious or Life-threatening conditions or diseases. Discussions followed with the FDA, Huu S. TIEU, and Golden Sunrise for FDA approval on new products and new indications on existing new Medical Technology and Innovation. It was agreed in Year-2015 that the FDA would take the request for new indications to the United States Congress to establish into FDA regulation and law. At that time the following was the FDA Guidance-"Emergency Use of a Test Ar-

Tiêu Equation Experimentation of Understanding by Energy Transfer Quantum Mechanics

“…These calculations will show the results of study subjects administered with the Innovation and the benefits received from are use. The theory and prediction by the author accurately predicted the Innovation as defined for Real-World Evidence as pre-clinical data regarding the usage, or the potential benefits or risks, of a drug derived from sources other than traditional clinical trials [26].…”

Patient Quality-of-Life, Providers with Incentive Payments, Real-World Evidence, and Reducing Healthcare Costs through New Innovations

“…See also under 21 st Century Cures Act [3] and Medicare for All Act [4]. The New Medical Innovation evidence-based care looks at Real-World Evidence [5] and Real-World Data [6] as proof the patient outcomes have improved from these therapies.…”